161 related articles for article (PubMed ID: 1528026)
1. Biochemistry and molecular biology of chronic granulomatous disease.
Segal AW
J Inherit Metab Dis; 1992; 15(4):683-6. PubMed ID: 1528026
[TBL] [Abstract][Full Text] [Related]
2. Identification of the defective NADPH-oxidase component in chronic granulomatous disease: a study of 57 European families.
Casimir C; Chetty M; Bohler MC; Garcia R; Fischer A; Griscelli C; Johnson B; Segal AW
Eur J Clin Invest; 1992 Jun; 22(6):403-6. PubMed ID: 1633835
[TBL] [Abstract][Full Text] [Related]
3. A point mutation in gp91-phox of cytochrome b558 of the human NADPH oxidase leading to defective translocation of the cytosolic proteins p47-phox and p67-phox.
Leusen JH; de Boer M; Bolscher BG; Hilarius PM; Weening RS; Ochs HD; Roos D; Verhoeven AJ
J Clin Invest; 1994 May; 93(5):2120-6. PubMed ID: 8182143
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil nicotinamide adenine dinucleotide phosphate oxidase assembly. Translocation of p47-phox and p67-phox requires interaction between p47-phox and cytochrome b558.
Heyworth PG; Curnutte JT; Nauseef WM; Volpp BD; Pearson DW; Rosen H; Clark RA
J Clin Invest; 1991 Jan; 87(1):352-6. PubMed ID: 1985107
[TBL] [Abstract][Full Text] [Related]
5. Complementation of NADPH oxidase in p67-phox-deficient CGD patients p67-phox/p40-phox interaction.
Vergnaud S; Paclet MH; El Benna J; Pocidalo MA; Morel F
Eur J Biochem; 2000 Feb; 267(4):1059-67. PubMed ID: 10672014
[TBL] [Abstract][Full Text] [Related]
6. Autosomal recessive chronic granulomatous disease with absence of the 67-kD cytosolic NADPH oxidase component: identification of mutation and detection of carriers.
de Boer M; Hilarius-Stokman PM; Hossle JP; Verhoeven AJ; Graf N; Kenney RT; Seger R; Roos D
Blood; 1994 Jan; 83(2):531-6. PubMed ID: 8286749
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome b-245 and its involvement in the molecular pathology of chronic granulomatous disease.
Segal AW
Hematol Oncol Clin North Am; 1988 Jun; 2(2):213-23. PubMed ID: 3292507
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome b-245 is a flavocytochrome containing FAD and the NADPH-binding site of the microbicidal oxidase of phagocytes.
Segal AW; West I; Wientjes F; Nugent JH; Chavan AJ; Haley B; Garcia RC; Rosen H; Scrace G
Biochem J; 1992 Jun; 284 ( Pt 3)(Pt 3):781-8. PubMed ID: 1320378
[TBL] [Abstract][Full Text] [Related]
9. Identification of a thermolabile component of the human neutrophil NADPH oxidase. A model for chronic granulomatous disease caused by deficiency of the p67-phox cytosolic component.
Erickson RW; Malawista SE; Garrett MC; Van Blaricom G; Leto TL; Curnutte JT
J Clin Invest; 1992 May; 89(5):1587-95. PubMed ID: 1314852
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis in three cases of X91- variant chronic granulomatous disease.
Bu-Ghanim HN; Segal AW; Keep NH; Casimir CM
Blood; 1995 Nov; 86(9):3575-82. PubMed ID: 7579466
[TBL] [Abstract][Full Text] [Related]
11. [Molecular aspects of chronic granulomatous disease. "the NADPH oxidase complex"].
Morel F
Bull Acad Natl Med; 2007 Feb; 191(2):377-90; discussion 390-2. PubMed ID: 17969555
[TBL] [Abstract][Full Text] [Related]
12. Chronic granulomatous disease. Molecular genetics.
Dinauer MC; Orkin SH
Hematol Oncol Clin North Am; 1988 Jun; 2(2):225-40. PubMed ID: 3292508
[TBL] [Abstract][Full Text] [Related]
13. Statistical and mutational analysis of chronic granulomatous disease in Japan with special reference to gp91-phox and p22-phox deficiency.
Ishibashi F; Nunoi H; Endo F; Matsuda I; Kanegasaki S
Hum Genet; 2000 May; 106(5):473-81. PubMed ID: 10914676
[TBL] [Abstract][Full Text] [Related]
14. The NADPH oxidase and chronic granulomatous disease.
Segal AW
Mol Med Today; 1996 Mar; 2(3):129-35. PubMed ID: 8796870
[TBL] [Abstract][Full Text] [Related]
15. Protein delivery by Pseudomonas type III secretion system: Ex vivo complementation of p67(phox)-deficient chronic granulomatous disease.
Polack B; Vergnaud S; Paclet MH; Lamotte D; Toussaint B; Morel F
Biochem Biophys Res Commun; 2000 Sep; 275(3):854-8. PubMed ID: 10973811
[TBL] [Abstract][Full Text] [Related]
16. Point mutation in the cytoplasmic domain of the neutrophil p22-phox cytochrome b subunit is associated with a nonfunctional NADPH oxidase and chronic granulomatous disease.
Dinauer MC; Pierce EA; Erickson RW; Muhlebach TJ; Messner H; Orkin SH; Seger RA; Curnutte JT
Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11231-5. PubMed ID: 1763037
[TBL] [Abstract][Full Text] [Related]
17. Detection of gp91-phox precursor protein in B-cell lines from patients with X-linked chronic granulomatous disease as an indicator for mutations impairing cytochrome b558 biosynthesis.
Porter CD; Kuribayashi F; Parkar MH; Roos D; Kinnon C
Biochem J; 1996 Apr; 315 ( Pt 2)(Pt 2):571-5. PubMed ID: 8615831
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic effects of proteoliposomes on X-linked chronic granulomatous disease: proof of concept using macrophages differentiated from patient-specific induced pluripotent stem cells.
Brault J; Vaganay G; Le Roy A; Lenormand JL; Cortes S; Stasia MJ
Int J Nanomedicine; 2017; 12():2161-2177. PubMed ID: 28356734
[TBL] [Abstract][Full Text] [Related]
19. Disturbed interaction of p21-rac with mutated p67-phox causes chronic granulomatous disease.
Leusen JH; de Klein A; Hilarius PM; Ahlin A; Palmblad J; Smith CI; Diekmann D; Hall A; Verhoeven AJ; Roos D
J Exp Med; 1996 Oct; 184(4):1243-9. PubMed ID: 8879195
[TBL] [Abstract][Full Text] [Related]
20. Molecular basis of the autosomal recessive forms of chronic granulomatous disease.
Curnutte JT
Immunodefic Rev; 1992; 3(2):149-72. PubMed ID: 1554499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
